Startup Funding News
Explore funding rounds, the companies behind them and the investors taking part.
- Rounds
- 752 All time
- Disclosed funding
- $25.4B 616 disclosed amounts
- Median round
- $15.8M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| AN Anodyne NanotechCompany profile Develops transdermal microneedle patches delivering GLP-1 and biologic therapeutics without injections Develops transdermal microneedle patches delivering GLP-1 and biologic therapeutics without injections | $12.6M | Series A | Healthtech, Biotech | United States | Investors | |
| RB RQ BioCompany profile Develops antibody therapies to prevent seasonal influenza in high-risk and immunocompromised patients Develops antibody therapies to prevent seasonal influenza in high-risk and immunocompromised patients | $115M | Series A | Healthtech, Biotech | United Kingdom | Investors | |
| C CroíValveCompany profile Develops a transcatheter device to treat tricuspid regurgitation in patients with structural heart disease Develops a transcatheter device to treat tricuspid regurgitation in patients with structural heart disease | $27M | Series B | Healthtech | Ireland | Investors | |
| RH Rapalogix HealthCompany profile Develops prescription therapeutics and skincare products for cellular longevity and skin health Develops prescription therapeutics and skincare products for cellular longevity and skin health | $20M | Series A | Healthtech, Biotech | United States | Investors | |
| C Automates chronic care for older adults using AI | $100M | Series CSeries C+ | Healthtech | United States | Investors | |
| NB NorthLinks BioCompany profile Develops broad-spectrum antiviral prophylactic therapies for respiratory infections Develops broad-spectrum antiviral prophylactic therapies for respiratory infections | $34M | Undisclosed | Healthtech, Biotech | United States | Investors | |
| OB Osanni BioCompany profile Platform that discovers and de-risks novel drug programs in ophthalmology and cardiology via affiliate company model Platform that discovers and de-risks novel drug programs in ophthalmology and cardiology via affiliate company model | $190M | Series B | Healthtech, Biotech | United States | Investors | |
| AS Astral SystemsCompany profile Develops multi-state fusion technology for medical radioisotopes and commercial applications Develops multi-state fusion technology for medical radioisotopes and commercial applications | £23M | Series A | Healthtech, Industrial tech | United Kingdom | Investors | |
| LH Ladder HealthCompany profile Delivers virtual-first AI-enabled pediatric developmental and therapeutic care for children and families Delivers virtual-first AI-enabled pediatric developmental and therapeutic care for children and families | $7M | Seed | Healthtech | United States | Investors | |
| BP Bionyra PharmaCompany profile Bionyra Pharma develops biologic therapies for severe immunological and inflammatory diseases. Bionyra Pharma develops biologic therapies for severe immunological and inflammatory diseases. | $165M | Series A | Healthtech, Biotech | France | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1General Catalyst
Baba, Disha (formerly Curelink), Thatch
23rounds2led - 2Y Combinator (YC)
Vitalize, Angle Health, Metriport
21rounds0led - 3Alumni Ventures
MintNeuro, Evvy, Hopscotch Primary Care
13rounds0led - 4Andreessen Horowitz (a16z)
Sharp Performance, General Medicine, Devoted Health
12rounds2led - 5Khosla Ventures
Even Healthcare, Abby Care, Rightway
11rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.
Browse rounds by topic
Geography
Featured selections
Nordic Foodtech Fund II pairs early capital with scientific expertise
An EIF pledge of up to €30m supports a fund targeting €80m for science-led agrifood companies.
Read the research →